The Diphtheria Tetanus Pertussis (DTP) Vaccine Market is witnessing strong growth driven by rising global immunization initiatives, government vaccination programs, and increasing awareness about the ...
In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis (DTP)-containing vaccine, and 85% – roughly 109 million – completed all three ...